The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment

Summary

To evaluate whether treatment with Estradiol supplementation during the luteal phase improves IVF outcomes Patients undergoing IVF treatment with controlled ovarian hyperstimulation using a GnRH analog will receive 4 mg estradiol valerate in the luteal phase.Patient's followup will include E2 progesterone and BHCG 14 days after embryo transfer and vaginal ultrasound on day 21 and 28 after embryo transfer

Timeline

Start

2007-08

Primary completion

—

Completion

2008-08

Drugs

Indications